“p-medicine - From data sharing and integration via VPH models to personalized medicine” is a 4 year integrated EU-project of the 7th Research Framework Program which develops new tools, IT-infrastructure, and simulation models for disease processes.
The purpose is to promote personalized medicine for the benefit of the patient. Nineteen partners from 9 European countries and Japan have joined forces in p-medicine to solve current problems of clinical research with new information and innovative technologies and to pave the way for stronger individualized therapies.
Information and knowledge from postgenetic research and from combined genetic and clinical studies, on the one hand, and progress in high performance computers and computer science, on the other hand, offers clinicians and scientists huge possibilities to improve the prognosis of cancer patients using individualized treatments. This makes the realization of personalized medicine possible.
Necessary conditions for the improvement of cancer therapies are the multi-level collection of data and biomaterial in clinical-genomic studies and their interdisciplinary analysis by clinicians, molecular biologists, and other specialists from life sciences.
For this purpose it is necessary to combine research data and results from biomolecular studies, imaging processes, scientific literature, and patients’ clinical data. This information must be analyzable by the user and available to all operators. The access to biomaterial with specific characteristics and its data also plays an important role. The p-medicine-partners combine their forces to establish an IT-infrastructure that promotes the transition from current practice to personalized medicine.